Beth C Seidenberg Acelyrin, Inc. (SLRN) insider trading activity

SLRN Quotes by TradingView
Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held N/A

BETH C SEIDENBERG Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2025
SELL
Sale (or disposition) back to the issuer
-
60,000 Reduced 100.0%
0 Common Stock
May 09 2023
BUY
Open market or private purchase
$1,080,000 $18.0 p/Share
60,000 Added 50.0%
60,000 Common Stock

Also insider at

PGNY
Progyny, Inc. Healthcare
Director
VERA
Vera Therapeutics, Inc. Healthcare
ATRA
Atara Biotherapeutics, Inc. Healthcare
SGMT
Sagimet Biosciences Inc.
Director
KYTX
Kyverna Therapeutics, Inc.
BCS

Beth C Seidenberg

Director
New York, NY

Track Institutional and Insider Activities on SLRN

Follow ACELYRIN, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLRN shares.

Notify only if

Insider Trading

Get notified when an Acelyrin, Inc. insider buys or sells SLRN shares.

Notify only if

News

Receive news related to ACELYRIN, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SLRN